Dr. Bharadwaj is fellowship-trained in blood and marrow transplantation, cellular therapy, hematology, and oncology. She is an instructor in the Stanford School of Medicine Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy.
Dr. Bharadwaj focuses her expertise on diagnosing and treating cancer in blood and bone marrow. For each patient, she develops a personalized, comprehensive, and compassionate care plan. In her diverse experience as a physician and scientist, she has served as an internal medicine doctor, hospitalist, hematologist, oncologist, and blood and marrow transplantation specialist. Dr. Bharadwaj has a degree in clinical research and is currently conducting clinical trials in transplant and cellular therapy.
She has participated in research studies of advances in therapy for chronic lymphocytic leukemia, melanoma, and breast cancer. She has co-authored articles published in Leukemia and Lymphoma and elsewhere. Topics include advances in cell transplantation. She also co-wrote the chapter on genome-driven personalized cancer therapy in the book Precision Medicine in Oncology.
Dr. Bharadwaj has made presentations at meetings of the American Society of Hematology, American Society of Clinical Oncology, and other associations.
Subjects include racial, demographic, and socioeconomic disparities in the treatment of patients with acute myeloid leukemia.
Dr. Bharadwaj is a member of the American Society for Transplantation and Cellular Therapy, American Society of Hematology, and American Society of Clinical Oncology.
- Cancer > Blood and Marrow Transplant
- Cancer > Hematology > Leukemia - Acute and Chronic
- Cancer > Lymphoma
Instructor, Medicine - Blood & Marrow Transplantation
Honors & Awards
Best Oral Presentation, Clinical Vignette Show and Tell Competition, John H. Stroger, Jr. Hospital of Cook County, Chicago
Organizational Excellence Award, South Zone Pharmacology Conference, Mangalore, India
Board Certification: American Board of Internal Medicine, Hematology (2021)
Board Certification: American Board of Internal Medicine, Internal Medicine (2021)
Fellowship: Stanford University Bone Marrow Transplant Fellowship (2021) CA
Fellowship: Cook County Health Hematology Oncology Fellowship (2020) IL
Residency: John H Stroger Jr Hospital of Cook County Internal Medicine Residency (2013) IL
Internship: University of Illinois College of Medicine at Peoria (2011) IL
Medical Education: Kasturba Medical College Mangalore (2006) India
- Significance of isolated deletion (20q) in donor cells after allogeneic hematopoietic cell transplantation LEUKEMIA & LYMPHOMA 2020; 61 (8): 2008-2011
Gender and glaucoma: what we know and what we need to know
CURRENT OPINION IN OPHTHALMOLOGY
2010; 21 (2): 91-99
With growing aging populations and an increase in cases of glaucoma and glaucoma blindness worldwide, aging populations are particularly at higher risk of glaucoma and glaucoma blindness. Awareness of the gender differences might increase attention toward populations at risk.Women not only outlive men, but also outnumber men in glaucoma cases worldwide. Women are at higher risks for angle closure glaucoma, but there is no clear gender predilection for open angle glaucoma. Of interest, there is some evidence suggesting that female sex hormones might be protective of the optic nerve. In addition, it is hypothesized that decreased estrogen exposure is associated with increased risk for open angle glaucoma, yet population-based studies present inconsistent results. Presently, there is insufficient evidence to support hormonal replacement therapy use in glaucoma prevention. In addition, it appears that women carry a larger burden of glaucoma blindness due to longevity and disadvantages in socioeconomic/health beliefs.Current evidence suggests that older women are at risk for glaucoma and glaucoma blindness. Further interdisciplinary research involving investigators, specialized in glaucoma, women's health and health disparities, will lead to better understanding of gender health disparities in glaucoma and better targeting populations at risk.
View details for DOI 10.1097/ICU.0b013e3283360b7e
View details for Web of Science ID 000275063500001
View details for PubMedID 20051857
View details for PubMedCentralID PMC4326058